subsequent sotalol therapy significantly reduced median arrhythmia frequency in patients receiving both low ( n = 19 ) and high ( n = 18 ) doses compared with that in patients receiving placebo ( by 77 and 83 % , respectively , versus 6 % ; p less than 0.001 ) .
C0037707
sotalol
C0003811
arrhythmia